Conclusions and recommendations from the symposium, Beyond Cholesterol: Prevention and Treatment of Coronary Heart Disease with n−3 Fatty Acids
Authors:
- Alexander LeafALAlexander Leaf
- Dariush MozaffarianDMDariush Mozaffarian
- Terry A JacobsonTJTerry A Jacobson
- William S HarrisWHWilliam S Harris
- Sharon R AkabasSASharon R Akabas
Open Access
- 1 June 2008
- journal article
- research article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 87 (6) , 2010S-2012S
Abstract
After the symposium “Beyond Cholesterol: Prevention and Treatment of Coronary Heart Disease with n−3 Fatty Acids,” faculty who presented at the conference submitted manuscripts relating to their conference topics, and these are presented in this supplement. The content of these manuscripts was reviewed, and 2 conference calls were convened. The objective was to summarize existing evidence, gaps in evidence, and future research needed to strengthen recommendations for specific intakes of n−3 fatty acids for different conditions relating to cardiovascular disease. The following 2 questions were the main items discussed. What are the roles of n−3 fatty acids in primary versus secondary prevention of coronary heart disease? What are the roles of n−3 fatty acids in hypertriglyceridemia, in the metabolic syndrome and type 2 diabetes, and in sudden cardiac death, cardiac arrhythmias, and vulnerable plaque? Each area was summarized by using 2 general categories: 1) current knowledge for which general consensus exists, and 2) recommendations for research and policy. Additional references for these conclusions can be found in the articles included in the supplement.Keywords
This publication has 12 references indexed in Scilit:
- Role of n−3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular diseaseThe American Journal of Clinical Nutrition, 2008
- Fish and n−3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac deathThe American Journal of Clinical Nutrition, 2008
- n-3 Fatty acids and cardiovascular disease: Actions and molecular mechanismsProstaglandins, Leukotrienes and Essential Fatty Acids, 2007
- Primary Prevention of Coronary Artery DiseaseNew England Journal of Medicine, 2007
- Prevention of sudden cardiac death by n-3 polyunsaturated fatty acidsJournal of Cardiovascular Medicine, 2007
- Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysisThe Lancet, 2007
- Fish Intake, Contaminants, and Human HealthJAMA, 2006
- n−3 Fatty acids and cardiovascular disease: navigating toward recommendations1,2The American Journal of Clinical Nutrition, 2006
- Prevention of Fatal Arrhythmias in High-Risk Subjects by Fish Oil n-3 Fatty Acid IntakeCirculation, 2005
- Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trialThe Lancet, 1999